Press Releases Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Market Closed - Nasdaq Other stock markets 01:30:00 01/06/2024 am IST			5-day change	1st Jan Change
0.968 ^USD	-0.43%		-9.53%	-48.78%

28/05	Bionano Genomics Raises $18 Million From Private Debentures Placement	MT
24/05	Bionano Genomics, Inc. announced that it has received $18 million in funding	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow	30/05	AQ
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet	28/05	AQ
Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy	21/05	AQ
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis	09/05	AQ
Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress	09/05	AQ
Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024	01/05	AQ
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference	01/05	AQ
Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing	25/04	AQ
Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing	24/04	AQ
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence	17/04	AQ
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing	11/04	AQ
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	04/04	AQ
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics	03/04	AQ
Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting	02/04	AQ
Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance	19/03	AQ
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System	07/03	AQ
Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024	06/03	AQ
Bionano to Present at TD Cowen’s 44th Annual Health Care Conference	29/02	AQ
Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024	28/02	AQ
Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway	28/02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Press Releases

Filters